hyperaldosteronism
HYPERALDOSTERONISM
Hyperaldosteronism is a group of disorders in which aldosterone production is inappropriately high, relatively autonomous & non-suppressible by sodium loading.
Signs & symptoms are nonspecific.
Symptoms are caused by hypertension (eg headache), hypokalemia (eg polyuria, nocturia, muscle cramps & weakness, tetany, paralysis, etc) & metabolic alkalosis.

Definition

  • Hyperaldosteronism is a group of disorders in which aldosterone production is inappropriately high, relatively autonomous and non-suppressible by sodium loading

Etiology

  • Hyperplasia eg idiopathic (bilateral) hyperplasia, primary (unilateral) adrenal hyperplasia
  • Familial Hyperaldosteronism II
    • Non-glucocorticoid remediable; maybe associated with familial occurrence of aldosterone-producing adenoma, idiopathic hyperaldosteronism, or both
Glucocorticoid-Remediable Aldosteronism (Familial Hyperaldosteronism I)
  • Monogenetic disorder related to hypertension
  • Adrenocortical hyperplasia is present which may be nodular
    • Histological features suggest over activity of the zona fasciculata
    • Progression to tumor has not been reported
  • Patients are usually asymptomatic young hypertensives
  • Diagnosis may be made with suppression of plasma aldosterone with Dexamethasone or southern blotting of genetic defect
  • Treat with low-dose Dexamethasone
Apparent Mineralocorticoid Excess
  • Rare congenital condition
  • Spironolactone may be used to control electrolyte imbalance
  • Blood pressure (BP) control usually needs other antihypertensive agents
    • Eg Angiotensin-converting enzyme (ACE) inhibitors, thiazide diuretics
  • Low-dose Dexamethasone may be useful

Liddle’s Syndrome

  • Rare congenital condition
  • Treat with Spironolactone but may also require Amiloride or Triamterene

Signs and Symptoms

  • Signs and symptoms are nonspecific
    • Symptoms caused by hypertension (eg headache), hypokalemia (eg polyuria, nocturia, muscle cramps and weakness, tetany, paralysis, etc), and metabolic alkalosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 20 Jul 2018
Women with pre-eclampsia or gestational hypertension during their first pregnancy had an increased risk of developing chronic hypertension, type 2 diabetes (T2D), and hypercholesterolaemia than those who were normotensive during pregnancy, according to a study. The risk persisted for several decades later, signalling these hypertensive disorders of pregnancy (HDP) as red flags for cardiovascular (CV) health for life.
Roshini Claire Anthony, 30 Jul 2018

Canagliflozin may provide a renoprotective effect in individuals with type 2 diabetes (T2D) and a history of cardiovascular disease (CVD), according to results from the CANVAS* Program.

Stephen Padilla, 31 Jul 2018
Patients with type 2 diabetes (T2D) treated with sulphonylureas as second-line drugs are at an increased risk of myocardial infarction (MI), all-cause mortality and severe hypoglycaemia compared with those who remained on metformin monotherapy, a recent study has found.
22 Jul 2018
There appears to be a nonlinear relationship between total oestradiol and free oestradiol and all-cause mortality among older men, according to data from the Three-City cohort study. Specifically, the association is stronger for cardiovascular disease mortality and nonexistent for cancer mortality.